Safety & Person-First Care

Trauma-Informed SBIRT & Perinatal Screening Guide

Prior trauma strongly predicts substance coping and clinic avoidance. Applying SAMHSA's six trauma-informed principles turns mandatory primary care screening into a collaborative safety conversation.

Evidence basis: SAMHSA Trauma-Informed & SBIRT Guidance and Pregnant Survivors Practice Guidelines (Hudson WIPHL Slides).

1. SAMHSA Six Principles Applied to Bedside Screening

Many patients presenting with hazardous alcohol use, sedative misuse, or chronic pain carry histories of interpersonal violence, adverse childhood experiences, or medical trauma. Confrontational questioning replicates loss of control and causes patients to underreport exposure or leave care.

• Safety: Conduct substance screening while the patient remains fully clothed before sensitive physical exams, never while lying supine in an exam gown.
• Trustworthiness and Transparency: State upfront why the clinic asks every patient the same questions and explain confidentiality and state mandatory-reporting boundaries clearly before screening.
• Peer Support: Position recovery coaches and lived-experience behavioral health peers as longitudinal allies rather than compliance monitors.
• Collaboration and Mutuality: Partner horizontally with patients in setting reduction or treatment goals rather than issuing unilateral directives.
• Empowerment, Voice, and Choice: Explicitly permit patients to skip any sensitive question or pause if an inquiry triggers distress.
• Cultural, Historical, and Gender Humility: Recognize disproportionate legal and child-welfare risks faced by pregnant and minority patients when substance use enters the medical record.

2. Stigma-Free Charting & Exam-Room Phrasing Matrix

3. Trauma-Informed Safety & Perinatal Triage Flow

In routine primary care practice, nearly half of patients presenting with hazardous alcohol or non-medical prescription sedative use report prior adverse childhood experiences, interpersonal violence, or medical trauma. When clinic staff administer substance screening abruptly during vitals or after a patient has already changed into an examination gown, physiological hyperarousal triggers protective silence or abrupt visit termination. Structuring the encounter around transparent consent, neutral curiosity, and clear confidentiality boundaries lowers defensive reactivity and improves diagnostic accuracy.

Clinicians should specifically screen for co-occurring intimate partner violence (IPV) privately after any partner, family member, or accompanying visitor steps out of the exam room. Validated brief IPV screens such as HITS or Hurt-Insult-Threaten-Scream pair naturally with substance screening when framed around total household safety rather than fault.

4. Perinatal 4P's Plus Screening & Pharmacotherapy Continuity

During pregnancy and the postpartum year, fear of punitive legal action or child protective investigation is the single largest barrier preventing patients from disclosing alcohol, cannabis, or opioid exposure. Traditional quantitative quantity-frequency questions also underperform in pregnancy because many patients sharply reduce intake once pregnancy is confirmed while remaining at high risk for return to use under postpartum stress or untreated depression.

The 4P's Plus verbal screening sequence evaluates four domains chronologically before asking about current intake: Parents (did either parent have a problem with alcohol or drugs), Partner (does your partner currently have a problem), Past (have you ever had difficulty with alcohol or substances in the past), and Pregnancy (in the month before you knew you were pregnant, how many beers, glasses of wine, or medications did you use). Anchoring the final question to the month prior to pregnancy recognition yields markedly higher disclosure sensitivity and invites collaborative prenatal counseling.

• Alcohol Exposure Counseling: Reaffirm that no amount of alcohol is established as safe during pregnancy, celebrate immediate cessation, assess folate/prenatal vitamin adherence, and connect patients needing withdrawal support to monitored medical stabilization rather than abrupt outpatient cessation if severe dependence is present.
• Opioid Use Disorder in Pregnancy: Abrupt opioid withdrawal during pregnancy increases risk of placental abruption, fetal distress, and return to unregulated fentanyl exposure. Maintain or initiate buprenorphine (monoproduct or combination formulation per current obstetric consensus) or coordinate daily methadone clinic linkage alongside prenatal care and take-home intranasal naloxone education.
• Postpartum Relapse Prevention: Schedule proactive two-week and six-week postpartum behavioral health check-ins, screen concurrently for postpartum depression with EPDS or PHQ-4, and involve peer recovery navigators early before sleep deprivation triggers recurrence.

For exam-room transition scripts and clinic readiness checks, pair this guide with the Warm-Handoff Integration Playbook and review outpatient dosing thresholds in the SBIRT Protocol Handbook.

5. Interactive Trauma-Informed Phrasing Selector

6. Perinatal Substance Screening & Retention Principles

Pregnant patients who fear punitive child-welfare reporting often delay prenatal visits or avoid disclosing alcohol, cannabis, or opioid use until delivery. Validated verbal screens such as the 4P's Plus (Parents, Partner, Past, Pregnancy) normalize risk conversation before pregnancy recognition and prioritize rapid linkage to perinatal obstetric-addiction co-management, including buprenorphine maintenance rather than medically unsafe acute opioid detoxification during pregnancy.

7. Trauma-Informed Care Questions